Thermo Fisher Scientific Inc.
Foreign stocks · NYSE · Healthcare · Scientific instruments
Sells instruments, reagents and services to laboratories, drug companies and hospitals, from analysers to contract drug manufacturing and clinical trials
For every 100 dollars of sales: cost of sales 59 · operating expenses 24 · tax and other items 2 · leaving 15 as net profit
Investors in Thailand can buy TMO through 37 mutual funds open to retail investors. Most of them (37 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds TMO.
| Fund | TMO weight | How it invests | 1-year return |
|---|---|---|---|
 K-GHEALTHK Global Healthcare Equity Fund | 4.70% | Via JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.26% |
| K-GHRMF |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
| Master fund | Thai funds using this route | Master fund's TMO weight |
|---|---|---|
| Janus Henderson Global Life Sciences Fund | 7 | 3.39% |
| GMO Quality Investment Fund | 4 | 4.60% |
| JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | 3 | 4.70% |
| JPMorgan Funds - Global Healthcare Fund | 3 | 4.58% |
| 4.70% |
| Via JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD |
| +16.44% |
 LHGEQRMFLH GLOBAL EQUITY RMF FUND | 4.60% | Via GMO Quality Investment Fund | +9.23% |
 KFHHCARE-AKrungsri Global Healthcare Equity Hedged FX Fund | 4.58% | Via JPMorgan Funds - Global Healthcare Fund | +15.06% |
 DAOL-GEQUITYDAOL GLOBAL EQUITY FUND | 4.58% | Via GMO Quality Investment Fund | +8.66% |
| KFHCARERMFKrungsri Global Healthcare Equity RMF | 4.57% | Via JPMorgan Funds - Global Healthcare Fund | +15.68% |
| LHGEQ-ALH GLOBAL EQUITY FUND | 4.57% | Via GMO Quality Investment Fund | +9.19% |
| KFHEALTH-AKrungsri Global Healthcare Equity Fund | 4.56% | Via JPMorgan Funds - Global Healthcare Fund | +23.48% |
| DAOL-GLOBALEQRMFDAOL GLOBAL EQUITY RETIREMENT MUTUAL FUND | 4.55% | Via GMO Quality Investment Fund | +8.91% |
 SCBGEQSCB GLOBAL EQUITY FUND | 4.51% | Via Veritas Global Focus | −1.70% |
Yearly average over the last 4 years · Latest annual sales 44.6B USD
For every 100 dollars of sales, about 15 dollars is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now close to its 1-year high
| Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue | 39.2B USD | 44.9B USD | 42.9B USD | 42.9B USD | 44.6B USD |
| Operating profit | 10.0B USD | 8.4B USD | 6.9B USD | 7.3B USD | 7.7B USD |
| Net profit |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 692.61 | 694.12 | Above |
| 20 days | 684.09 | 685.61 | Above |
| 50 days | 658.67 | 657.82 | Above |
| 100 days | 603.29 | 618.70 | Above |
| 200 days |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 60.57 | Up |
| MACD(12,26) | 12.08 | Up |
| ADX(14) | 32.47 | Neutral |
| ATR(14) % of price | 1.39 | Neutral |
SCBAM5
MFC4KASSET3LHFUND3DAOLINV3
TISCOASSET3
UOBAM3| Fund | TMO weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| K-GHEALTH | 4.70% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.26% | 1.75% |
| K-GHRMF | 4.70% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +16.44% | 1.74% |
| LHGEQRMF | 4.60% | GMO Quality Investment Fund | +9.23% | 2.47% |
| KFHHCARE-A | 4.58% | JPMorgan Funds - Global Healthcare Fund | +15.06% | 1.54% |
| DAOL-GEQUITY | 4.58% | GMO Quality Investment Fund | +8.66% | 2.28% |
| KFHCARERMF | 4.57% | JPMorgan Funds - Global Healthcare Fund | +15.68% | 1.54% |
| LHGEQ-A | 4.57% | GMO Quality Investment Fund | +9.19% | 2.34% |
| KFHEALTH-A | 4.56% | JPMorgan Funds - Global Healthcare Fund | +23.48% | 1.53% |
| DAOL-GLOBALEQRMF | 4.55% | GMO Quality Investment Fund | +8.91% | 2.53% |
| SCBGEQ | 4.51% | Veritas Global Focus | −1.70% | 1.72% |
| K-GHEALTH(UH) | 4.46% | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | +22.56% | 1.76% |
| LHGALPHA | 4.42% | Fullerton Lux Funds - Global Absolute Alpha | N/A | 2.10% |
| MHEALTHG | 4.21% | BGF World Healthscience Fund | +17.59% | 2.00% |
| MHEALTHRMF | 4.12% | BGF World Healthscience Fund | +18.34% | 1.81% |
| SCBIHEALT(SSFE) | 4.12% | BNP Paribas Funds Health Care Innovators | +15.53% | 0.11% |
| TUSHEALTH-A | 4.02% | XLV | +23.08% | 1.31% |
| KF-QUALITYRMF | 3.80% | Morgan Stanley Investment Funds - Global Brands Fund | −8.59% | 1.53% |
| KF-QUALITYSSF | 3.77% | Morgan Stanley Investment Funds - Global Brands Fund | −8.47% | 1.54% |
| SCBCLIMATE(A) | 3.77% | Templeton Global Climate Change Fund | +18.30% | 1.74% |
| KF-QUALITY-ID | 3.75% | Morgan Stanley Investment Funds - Global Brands Fund | −8.54% | 1.53% |
| Fund | TMO weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| DAOL-GSECURE | 3.43% | CS Investment Funds 2-UBS (Lux) Security Equity Fund | +11.72% | 2.14% |
| SCBGHC | 3.39% | Janus Henderson Global Life Sciences Fund | +19.10% | 1.72% |
 KT-HEALTHCARE-A | 3.34% | Janus Henderson Global Life Sciences Fund | +20.31% | 1.34% |
| SCBRMGHC | 3.32% | Janus Henderson Global Life Sciences Fund | +19.18% | 1.18% |
| KT-HEALTHC RMF | 3.32% | Janus Henderson Global Life Sciences Fund | +20.06% | 1.97% |
 KKP GHC-A | 3.31% | Janus Henderson Global Life Sciences Fund | +18.96% | 1.21% |
 ES-HEALTHCARERMF | 3.27% | Janus Henderson Global Life Sciences Fund | +18.85% | 1.78% |
| ES-HEALTHCARE | 3.27% | Janus Henderson Global Life Sciences Fund | +19.67% | 1.24% |
 FP HCARE-A | 3.16% | Manulife Global Fund – Healthcare Fund | +26.97% | 2.19% |
| TGHRMF-A | 2.94% | several master funds (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | +20.61% | 1.60% |
| MGFRMF | 2.62% | Threadneedle (Lux) - Global Focus Fund | +6.44% | 1.75% |
| MGFGA | 2.61% | Threadneedle (Lux) - Global Focus Fund | +5.97% | 1.76% |
| TGHSTARP | 2.55% | several master funds (BlackRock Global Funds - World Healthscience) | +15.44% | 1.90% |
| KKP G-THEME-H | 2.49% | Lazard Global Thematic Focus Fund | −1.51% | 1.49% |
| UGSTAR | 2.40% | Robeco Global Stars Equities IL USD | +1.62% | 1.86% |
| UGQG | 1.78% | United Global Quality Growth Fund (Class USD Acc) | −3.16% | 1.69% |
| UGQGRMF | 1.77% | United Global Quality Growth Fund (Class USD Acc) | −2.94% | 1.69% |
| Morgan Stanley Investment Funds - Global Brands Fund |
| 3 |
| 3.80% |
| BGF World Healthscience Fund | 2 | 4.21% |
| Threadneedle (Lux) - Global Focus Fund | 2 | 2.62% |
| United Global Quality Growth Fund (Class USD Acc) | 2 | 1.78% |
| Veritas Global Focus | 1 | 4.51% |
| Fullerton Lux Funds - Global Absolute Alpha | 1 | 4.42% |
| BNP Paribas Funds Health Care Innovators | 1 | 4.12% |
| State Street Health Care Select Sector SPDR ETF | 1 | 4.02% |
| Templeton Global Climate Change Fund | 1 | 3.77% |
| CS Investment Funds 2-UBS (Lux) Security Equity Fund | 1 | 3.43% |
| Manulife Global Fund – Healthcare Fund | 1 | 3.16% |
| 7.7B USD |
| 7.0B USD |
| 6.0B USD |
| 6.3B USD |
| 6.7B USD |
| EPS (diluted) | 19.46 | 17.63 | 15.45 | 16.53 | 17.74 |
| Operating margin | 25.6% | 18.7% | 16.0% | 17.1% | 17.4% |
| Net margin | 19.7% | 15.5% | 14.0% | 14.8% | 15.0% |
| Operating cash flow | 9.3B USD | 9.2B USD | 8.4B USD | 8.7B USD | 7.8B USD |
| Free cash flow | 6.8B USD | 6.9B USD | 6.9B USD | 7.3B USD | 6.3B USD |
| Total assets | 95.1B USD | 97.2B USD | 98.7B USD | 97.3B USD | 110.3B USD |
| Total liabilities | 54.3B USD | 53.1B USD | 52.0B USD | 47.8B USD | 56.9B USD |
| Shareholders' equity | 40.9B USD | 44.0B USD | 46.7B USD | 49.6B USD | 53.4B USD |
| 552.49 |
| 579.58 |
| Above |
